Literature DB >> 10899046

Transmural distribution of FDG uptake in stunned myocardium.

J A Fallavollita1, C Trojan, J M Canty.   

Abstract

Fasting [(18)F]fluoro-2-deoxyglucose (FDG) uptake is increased in viable, chronically dysfunctional myocardium, but the relationship to acute episodes of ischemia remains undefined. To investigate FDG uptake in acute stunning, chronically instrumented pigs (n = 9) and sham controls (n = 8) were studied while in a fasted, closed-chest, anesthetized state. One-hour partial occlusion reduced subendocardial flow from 1.24 +/- 0.14 to 0.35 +/- 0.06 ml. min(-1). g(-1) and wall thickening from 16.8 +/- 2.1 to 3.7 +/- 0.7%. Regional function remained depressed during reperfusion (8.3 +/- 1. 4%) despite the return of flow to resting levels. Triphenyl tetrazolium chloride staining showed no irreversible injury. FDG uptake in stunned myocardium was variably increased and averaged 1. 5-fold higher than that of normal regions, with no consistent transmural variation. Subgroup analysis showed that variability in FDG uptake was related to alterations in insulin levels that varied directly with ischemic risk region.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10899046     DOI: 10.1152/ajpheart.2000.279.1.H102

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  3 in total

1.  Blood flow, flow reserve, and glucose utilization in viable and nonviable myocardium in patients with ischemic cardiomyopathy.

Authors:  Xiaoli Zhang; Thomas H Schindler; John O Prior; James Sayre; Magnus Dahlbom; Sung-Cheng Huang; Heinrich R Schelbert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-01-04       Impact factor: 9.236

2.  Determinants of delayed preconditioning against myocardial stunning in chronically-instrumented pigs.

Authors:  James A Fallavollita
Journal:  J Cardiovasc Transl Res       Date:  2009-03       Impact factor: 4.132

3.  Incidence of stunned, hibernating and scarred myocardium in ischaemic cardiomyopathy.

Authors:  Miguel Hernandez-Pampaloni; Jeroen J Bax; Koichi Morita; David P Dutka; Paolo G Camici
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-10-12       Impact factor: 9.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.